• BACH 1 Inhibitors could be Key for Blood Vessel Growth

News & Views

BACH 1 Inhibitors could be Key for Blood Vessel Growth

Feb 18 2020

A new method for stimulating the growth of new blood vessels in the heart thus increasing blood flow to damaged tissue, will be investigated by researchers at the University of Bristol with funding of over £100,000 from national charity Heart Research UK.

.A team, led by Professor Paolo Madeddu, Chair of Experimental Cardiovascular Medicine at Bristol, discovered that an excess of a protein called BACH1 can prevent blood vessel formation. They hope to show that the use of BACH1 inhibitors can stimulate the growth of new blood vessels and if successful lead to development of drug treatments for heart disease. The treatment could also benefit people suffering from other diseases such as poor blood circulation in the legs, or damage to other organs, such as the kidney, brain and eyes.

Professor Madeddu said: "The use of BACH1 inhibitors is a very promising area of study that promises to have a huge impact on the way that we treat a wide range of conditions.

"If we are successful, the door will be opened for a whole new method of treating people who have suffered damage to their hearts. The ability to stimulate the growth of new blood vessels will allow us to drastically improve the quality of life of patients who may be at risk of heart failure. We're very grateful to Heart Research UK for allowing us to undertake this research."

Digital Edition

Lab Asia 31.3 June 2024

June 2024

Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - UV-Vis and fluorescence spectroscopy illumina...

View all digital editions



Jun 26 2024 Tokyo, Japan

Asia Labex

Jul 03 2024 Gandhinagar, India

EuCheMS Chemistry Congress

Jul 07 2024 Dublin, Ireland

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

View all events